Special Issue "Personalized Diagnosis and Management of Gastric Cancer"
Deadline for manuscript submissions: closed (31 August 2023) | Viewed by 157
Interests: gastric cancer; diagnosis; treatment; proliferation; metastasis; biomarkers; precancerous lesions; experimental medicine; disease management; epidemiology
Gastric cancer (GC) is one of the most common tumors in the world and a leading cause of tumor-related death. Endoscopy and serological tumor marker detection are the main methods for gastric cancer screening, and the treatment depends on surgical resection or chemotherapy.
Early screening, prognostic monitoring, and the prevention and treatment of gastric cancer have made rapid progress in recent years. In particular, liquid biopsy, gastric microbiota, and the tumor microenvironment have more research characteristics and application prospects.
We are pleased to invite you to submit papers with the results of basic research on gastric cancer aimed at improving the technologies for the prevention, diagnosis, risk assessment, and treatment of gastric cancer from the standpoint of personalized medicine.
This Special Issue aims to familiarize physicians and researchers with the latest advances in the basic and clinical research of gastric cancer from the standpoint of personalized medicine.
In this Special Issue, original research articles and reviews are welcome. Research areas may include (but are not limited to) the following:
- Clinical application and detection techniques of liquid biopsy in gastric cancer;
- Helicobacter pylori infection and gastric cancer;
- Immunotherapy in gastric cancer;
- Carcinogens in gastric cancer;
- Color imaging for gastric cancer screening;
- Epstein–Barr-virus-associated gastric cancer;
- Proximal gastric cancer or esophagogastric junction cancer;
- Gastric cancer risk and pathogenesis;
- Diagnosis and management of gastric cancer;
- The photodynamic therapy for gastric cancer;
- Gastric microbiota in gastric cancer;
- Tumor microenvironment of gastric cancer.
We look forward to receiving your contributions.
Dr. Yuping Wang
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Personalized Medicine is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- gastric cancer
- tumor microenvironment
- precancerous lesions
- experimental medicine
- liquid biopsy